{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:43:24Z","timestamp":1791315804349,"version":"4.3.1"},"reference-count":11,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T00:00:00Z","timestamp":1690502400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Disorders of immunity are poorly recognised in some rare multisystem genetic conditions. We aim to describe syndromic features and immunological defects in children with syndromic primary immunodeficiencies (sPIDs). Methods: This is a retrospective descriptive study of children aged 0\u201318 years with sPIDs under the care of the paediatric immunology service at the Bristol Royal Hospital for Children, United Kingdom, from January 2006 to September 2021. Results: sPIDs were identified in 36 patients. Genetic diagnoses which are not commonly associated with PIDs and not included in the International Union of Immunological Societies classification were present in 7\/36 (19%): Trisomy 22, Arboleda-Tham syndrome, 2p16.3 deletion syndrome, supernumerary ring chromosome 20 syndrome, Myhre syndrome, Noonan syndrome, and trichothiodystrophy\/Cockayne syndrome complex. Recurrent and\/or severe infections were the most common clinical features (n = 33, 92%). Approximately half had combined immunodeficiency or antibody deficiency. The most common extra-immunological manifestations include dysmorphism (72%), disorders of nervous (78%), musculoskeletal (69%), haematology\/lymphatic (58%), and gastrointestinal, hepatic\/pancreatic (58%) systems. Conclusions: Patients with sPIDs often have multiorgan involvement and some are non-immunologically mediated. There should be a low threshold to clinically assess and investigate for disorders of immunity in any patients with syndromic features especially when they present with recurrent\/severe\/opportunistic infections, features of immune dysregulation, autoinflammation or lymphoproliferation.<\/jats:p>","DOI":"10.3390\/jcm12154964","type":"journal-article","created":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T07:58:52Z","timestamp":1690531132000},"page":"4964","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The Multifaceted Syndromic Primary Immunodeficiencies in Children"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8767-3974","authenticated-orcid":false,"given":"Khuen Foong","family":"Ng","sequence":"first","affiliation":[{"name":"Department of Paediatric Immunology and Infectious Diseases, Bristol Royal Hospital for Children, Bristol BS1 3NU, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8152-2155","authenticated-orcid":false,"given":"Anu","family":"Goenka","sequence":"additional","affiliation":[{"name":"Department of Paediatric Immunology and Infectious Diseases, Bristol Royal Hospital for Children, Bristol BS1 3NU, UK"},{"name":"Cellular and Molecular Medicine, University of Bristol, Bristol BS8 1TD, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Manyika","sequence":"additional","affiliation":[{"name":"Department of Paediatric Immunology and Infectious Diseases, Bristol Royal Hospital for Children, Bristol BS1 3NU, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanta","family":"Bernatoniene","sequence":"additional","affiliation":[{"name":"Department of Paediatric Immunology and Infectious Diseases, Bristol Royal Hospital for Children, Bristol BS1 3NU, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,7,28]]},"reference":[{"key":"ref_1","unstructured":"(2019). Working Definitions for Clinical Diagnosis of PID, European Society for Immunodeficiencies Registry Working Party."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1007\/s10875-022-01289-3","article-title":"Human Inborn Errors of Immunity: 2022 Update on the Classification from the International Union of Immunological Societies Expert Committee","volume":"42","author":"Tangye","year":"2022","journal-title":"J. Clin. Immunol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/s41586-020-2265-1","article-title":"Whole-genome sequencing of a sporadic primary immunodeficiency cohort","volume":"583","author":"Thaventhiran","year":"2020","journal-title":"Nature"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.mad.2008.01.005","article-title":"Clinical implications of the basic defects in Cockayne syndrome and xeroderma pigmentosum and the DNA lesions responsible for cancer, neurodegeneration and aging","volume":"129","author":"Cleaver","year":"2008","journal-title":"Mech. Ageing Dev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.braindev.2020.09.007","article-title":"Immunodeficiency in a patient with microcephalic osteodysplastic primordial dwarfism type I as compared to Roifman syndrome","volume":"43","author":"Hagiwara","year":"2021","journal-title":"Brain Dev."},{"key":"ref_6","first-page":"313","article-title":"Thymic hormone dependent immunodeficiency in an infant with partial trisomy of chromosome 22","volume":"8","author":"Tovo","year":"1986","journal-title":"Thymus"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e1266","DOI":"10.1002\/cti2.1266","article-title":"Primary immunodeficiency-related genes in neonatal intensive care unit patients with various genetic immune abnormalities: A multicentre study in China","volume":"10","author":"Zhu","year":"2021","journal-title":"Clin. Transl. Immunol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/MOP.0000000000000833","article-title":"Autoimmunity as a continuum in primary immunodeficiency","volume":"31","author":"Walter","year":"2019","journal-title":"Curr. Opin. Pediatr."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.jaci.2021.04.015","article-title":"Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations","volume":"148","author":"Thalhammer","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"509","DOI":"10.2217\/phe.10.57","article-title":"An overview of infectious complications in children on new biologic response-modifying agents","volume":"4","author":"Abinun","year":"2010","journal-title":"Pediatr. Health"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.3389\/fimmu.2018.01439","article-title":"Changing the Lives of People With Primary Immunodeficiencies (PI) with Early Testing and Diagnosis","volume":"9","year":"2018","journal-title":"Front. Immunol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/15\/4964\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:21:17Z","timestamp":1760127677000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/15\/4964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,28]]},"references-count":11,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2023,8]]}},"alternative-id":["jcm12154964"],"URL":"https:\/\/doi.org\/10.3390\/jcm12154964","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,28]]}}}